Enavate Sciences Gp, LLC 13F Holdings · Q2 2026
Enavate Sciences Gp, LLC reported 7 securities worth $345.38M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: SION (31.56%), ZBIO (28.80%), IMNM (22.17%). Among its top 25 positions this quarter: 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SION | SIONNA THERAPEUTICS INC | $109.0M | 31.56% | 2.5M | Hold |
| 2 | ZBIO | ZENAS BIOPHARMA INC | $99.5M | 28.80% | 3.9M | Hold |
| 3 | IMNM | IMMUNOME INC | $76.6M | 22.17% | 3.6M | Hold |
| 4 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $20.0M | 5.80% | 2.6M | Hold |
| 5 | CMPX | COMPASS THERAPEUTICS INC | $17.1M | 4.94% | 7.8M | Hold |
| 6 | UPB | UPSTREAM BIO INC | $17.0M | 4.93% | 2.5M | Hold |
| 7 | CAMP | CAMP4 THERAPEUTICS CORP | $6.2M | 1.80% | 1.4M | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR